NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
September 5, 2006 • Volume 3 / Number 34 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Gene Therapy Offers Treatment for Metastatic Melanoma

Director's Update
NCI Committed to Colorectal Cancer Prevention

Cancer Research Highlights
New Models of Breast Cancer Risk Focus on Breast Density

Celecoxib Significantly Reduces the Risk of Precancerous Colorectal Polyps

Overweight, Obesity in Midlife Increases Risk of Mortality

Suicidality Increased in Adult Survivors of Childhood Cancer

CCR Grand Rounds

Spotlight
After Avastin, Testing Theories about Blood Vessels and Cancer

Funding Opportunities

Featured Clinical Trial
Bevacizumab for Hormone-Refractory Prostate Cancer

Notes
NCI, FDA, Standards Institute to Collaborate on Nanotech Activities

New Members Appointed to DCLG

NCI Hosts Science Writers' Seminar on Cancer in Minority Populations

CCOP Profile
Upstate Carolina Community Clinical Oncology Program

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Funding Opportunities Funding Opportunities

Following are newly released NCI research funding opportunities:

Innovations in Biomedical Computational Science and Technology Initiative
Announcement Number: PAR-06-534
Application Receipt Date: Sept. 24, 2006

This is a renewal of PAR-06-089 and will use the R41/R42 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3525. Inquiries: Dr. Peter Lyster - lysterp@mail.nih.gov

Innovations in Biomedical Computational Science and Technology Initiative
Announcement Number: PAR-06-535
Application Receipt Date: Sept. 24, 2006

This is a renewal of PAR-06-088 and will use the R43/R44 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3526. Inquiries: Dr. Peter Lyster - lysterp@mail.nih.gov

Technology Development of Image-Guided Interventions: Phase I
Announcement Number: RFA-EB-06-003
Letter of Intent Receipt Date: Sept. 25, 2006
Application Receipt Date: Oct. 23, 2006

This funding opportunity will use the R21 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3529. Inquiries: Dr. Keyvan Farahani - farahank@mail.nih.gov.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov